Alnylam Pharmaceuticals, Inc. (ALNY)
NASDAQ: ALNY · Real-Time Price · USD
460.54
+11.38 (2.53%)
At close: Nov 17, 2025, 4:00 PM EST
466.00
+5.46 (1.19%)
After-hours: Nov 17, 2025, 7:59 PM EST

Alnylam Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202015 - 2019
Period Ending
Nov '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
60,84430,35024,02129,23820,28215,100
Upgrade
Market Cap Growth
68.37%26.35%-17.84%44.16%34.32%17.60%
Upgrade
Enterprise Value
60,89230,29624,27829,56419,87314,639
Upgrade
Last Close Price
460.54235.31191.41237.65169.58129.97
Upgrade
PS Ratio
18.6813.5013.1428.1824.0230.64
Upgrade
PB Ratio
259.50452.40-108.87-184.7934.4814.86
Upgrade
P/TBV Ratio
260.13452.40--34.4814.86
Upgrade
P/FCF Ratio
274.86-572.67---
Upgrade
P/OCF Ratio
228.85-230.62---
Upgrade
EV/Sales Ratio
18.9713.4813.2828.5023.5429.70
Upgrade
EV/FCF Ratio
275.08-578.81---
Upgrade
Debt / Equity Ratio
11.8640.89-12.16-16.513.721.57
Upgrade
Debt / FCF Ratio
12.53-63.96---
Upgrade
Asset Turnover
0.710.560.500.290.240.17
Upgrade
Inventory Turnover
6.833.862.851.571.741.19
Upgrade
Quick Ratio
2.372.612.863.173.794.23
Upgrade
Current Ratio
2.542.783.083.514.044.47
Upgrade
Return on Equity (ROE)
32.73%---526.14%-106.31%-69.92%
Upgrade
Return on Assets (ROA)
3.65%-2.74%-4.78%-13.65%-12.56%-17.85%
Upgrade
Return on Capital (ROIC)
5.74%-4.19%-7.17%-18.77%-16.46%-23.80%
Upgrade
Return on Capital Employed (ROCE)
8.00%-5.80%-9.90%-28.30%-24.00%-29.40%
Upgrade
Earnings Yield
0.07%-0.92%-1.83%-3.87%-4.21%-5.68%
Upgrade
FCF Yield
0.36%-0.14%0.18%-2.10%-3.54%-4.54%
Upgrade
Buyback Yield / Dilution
-4.82%-2.20%-2.64%-2.73%-3.01%-5.24%
Upgrade
Updated Oct 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q